Subspecialties: Page 1260

Elekta signs U. of Virginia

By AuntMinnie.com staff writers

Swedish radiation therapy firm Elekta will be installing its Leksell Gamma Knife Perfexion at the University of Virginia Health System in Charlottesville.

September 5, 2006

Cordis gets CE Mark for Cypher Select

By AuntMinnie.com staff writers

Johnson & Johnson subsidiary Cordis Endovascular has received the European CE Mark for its Cypher Select sirolimus-eluting stent.

September 5, 2006

More data will be key to CTA reimbursement

By Wayne Forrest

To reach appropriate reimbursement levels, Dr. Geoffrey Rubin, professor of radiology at Stanford University in California, said several criteria must first be met. In his presentation at Stanford's 2006 International Symposium on Multidetector-Row CT in San Francisco, Rubin outlined several technology assessment steps that Blue Cross and Blue Shield uses on a national level to determine the value of technology and its benefit to healthcare.

September 5, 2006

Multislice CT almost as good as IVUS in acute coronary syndromes

By Edward Susman

BARCELONA - In the early stage of acute coronary syndrome, 16-slice multidetector-row CT can locate the culprit lesion, according to a presentation this week at the European Society of Cardiology's World Congress of Cardiology. Researchers from University Hospital in Bordeaux, France compared 16-slice CT to 40-MHz catheter-based intravascular ultrasound (IVUS).

September 5, 2006

MRI market to top $4 billion by 2010

By AuntMinnie.com staff writers

Increases in the use of interventional MRI in brain surgery will drive the worldwide MRI market to $4 billion in anticipated revenues by 2010, according to research firm Kalorama Information.

September 4, 2006

From tears to TKA: The ins and outs of knee MRI

By Shalmali Pal

Whether it's an injury of the MCL, POL, or PCL, MRI can be the go-to modality for knee imaging. Dr. Douglas Beall from Oklahoma City offered his tips on getting the most out this modality at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle. Beall covered old school topics (injury grading) as well as newer ones (postarthroplasty complications) in knee MRI.

September 4, 2006

Better enhancement, fewer artifacts seen with certain -- but not all -- MR contrast agents

By Shalmali Pal

Two new studies evaluated three different MR contrast agents for brain and spinal imaging. In the first study, a multi-institutional group compared two gadolinium-based contrast agents for the enhancement of central nervous system (CNS) lesions. In the second, researchers tested a half-life gadolinium-based contrast agent in functional MRI (fMRI).

September 4, 2006

Medicare changes, joint meetings spell progress for VC

By Eric Barnes

Virtual colonoscopy is making progress locally in the U.S. as regional Medicare carriers add indications. And a national meeting between the American Cancer Society and colorectal cancer experts promises a new airing of ideas for screening solutions.

September 3, 2006

Stress MPI with Tc-99m SPECT identifies high-risk obese patients

By Jonathan S. Batchelor

Identifying an accurate method for risk stratification of obese patients with coronary artery disease is critically important to limit invasive procedures for high-risk patients, according to researchers from the U.S. and the Netherlands. They found that stress myocardial perfusion imaging (MPI) with Tc-99m tetrofosmin is a valuable, noninvasive tool for predicting mortality and cardiac events in obese patients.

August 31, 2006

Horseshoe kidney AAA

A volume-rendered 360° rotation series showing a preop abdominal aortic aneurysm (AAA) patient with a horseshoe kidney and multiple renal arteries bilateraly.

August 30, 2006

Elekta inks US Oncology deal

By AuntMinnie.com staff writers

Swedish radiation therapy firm Elekta said it has signed an agreement with radiation therapy center operator US Oncology of Houston outlining pricing as well as terms and conditions for Elekta's technology for intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

August 30, 2006

Boston Scientific reaches halfway point in drug-eluting stent trial

By AuntMinnie.com staff writers

Interventional device developer Boston Scientific of Natick, MA, reported that enrollment has exceeded 13,000 patients in the Taxus Olympia registry, designed to evaluate the safety and performance of its second-generation drug-eluting coronary stent, the Taxus Liberté.

August 30, 2006

Previous Page

Page 1260 of 1583

Next Page